• A Th Zaralidou, E N Amaniti, P G Maidatsi, N K Gorgias, and D F Vasilakos.
• Department of Anesthesiology, Pain Clinic, AHEPA University Hospital, Thessaloniki, Greece.
• Methods Find Exp Clin Pharmacol. 2007 Jun 1;29(5):353-7.

AbstractMyofascial pain syndromes are characterized by the presence of painful loci within muscles, tendons or ligaments, called trigger points. Infiltration of these points with local anesthetics is often used as a treatment modality. The aim of the study was to comparatively evaluate 0.25% levobupivacaine and 0.25% ropivacaine for trigger point injection regarding pain on injection, treatment efficacy and duration of symptoms remission. Sixty-eight patients, suffering from myofascial pain syndromes, were randomly assigned to two groups to receive either levobupivacaine or ropivacaine for trigger-point injection. After completion of the procedure, patients were asked to rate pain during injection and efficacy of the treatment, based on immediate relief. Two weeks later, they were asked about the duration of this relief. Statistical analysis did not reveal significant differences between groups with respect to pain during injection, efficacy of the treatment and duration of pain relief. The two local anesthetics seem to be equally effective for trigger point infiltration.(c) 2007 Prous Science. All rights reserved.

22 keywords...

hide…